In the INTEGUMENT-INFANT trial, 34.4% of patients achieved vIGA-AD success and 58.3% reached EASI-75 at week 4.

Arcutis Biotherapeutics said the U.S. Food and Drug Administration has accepted its application seeking expanded approval of its Zoryve topical treatment for infants with atopic dermatitis, the most ...

FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...

When doctors chat with patients eye to eye, it’s not just about creating rapport. Certain facial traits may reveal vital clues to underlying health conditions. The post 9 Signs of Disease That Are ...

Dupixent (dupilumab) is one of the most widely prescribed biologic medications in the United States. Doctors use it to treat ...

If you’re wondering why you’re feeling itchy down there, doctors explain there are some common reasons for vaginal itching. “The most common causes of vulvovaginal itching are infections, such as ...

ZORYVE cream 0.3% is the first once-daily, non-steroidal therapy approved for children with plaque psoriasis as young as 2 years of ageZORYVE ...

The online team-based connected health (TCH) model yields equivalent improvements in signs and symptoms of atopic dermatitis ...

There’s a difference between a minor irritation and a skin rash that needs medical attention. That’s where pictures of skin rashes, along with dermatologists’ input, can come into play and help you ...

Atopic dermatitis is the most common type of eczema, a long-lasting skin condition that occurs most often in children but can affect people of any age. Atopic dermatitis can cause itchy skin, dry or ...

Panelists discuss how atopic dermatitis involves complex inflammatory and neuronal pathways, with IL-4, IL-13, and IL-31 cytokines driving Th2-mediated inflammation that varies across different racial ...